3151 Stock Overview
Engages in the wholesale and retail sale of pharmaceutical products in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Vital KSK Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥1,144.00 |
| 52 Week High | JP¥1,439.00 |
| 52 Week Low | JP¥1,019.00 |
| Beta | 0.052 |
| 1 Month Change | -2.72% |
| 3 Month Change | -6.23% |
| 1 Year Change | 7.92% |
| 3 Year Change | 43.36% |
| 5 Year Change | 7.52% |
| Change since IPO | 105.02% |
Recent News & Updates
Vital KSK Holdings' (TSE:3151) Dividend Will Be ¥22.00
Dec 04
Vital KSK Holdings' (TSE:3151) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 20Recent updates
Vital KSK Holdings' (TSE:3151) Dividend Will Be ¥22.00
Dec 04Vital KSK Holdings' (TSE:3151) Shareholders May Want To Dig Deeper Than Statutory Profit
Nov 20These 4 Measures Indicate That Vital KSK Holdings (TSE:3151) Is Using Debt Safely
Aug 07Impressive Earnings May Not Tell The Whole Story For Vital KSK Holdings (TSE:3151)
May 22Shareholder Returns
| 3151 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0.4% | -2.0% | -1.5% |
| 1Y | 7.9% | -9.4% | 13.7% |
Return vs Industry: 3151 exceeded the JP Healthcare industry which returned -9.4% over the past year.
Return vs Market: 3151 underperformed the JP Market which returned 13.7% over the past year.
Price Volatility
| 3151 volatility | |
|---|---|
| 3151 Average Weekly Movement | 3.9% |
| Healthcare Industry Average Movement | 3.3% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.3% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 3151 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3151's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | 3,705 | Taisuke Murai | www.vitalksk.co.jp |
Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan. The company is involved in the nursing care, agrochemical wholesale, and veterinary drug wholesale business. It also engages in the medical and pharmacy consulting business.
Vital KSK Holdings, Inc. Fundamentals Summary
| 3151 fundamental statistics | |
|---|---|
| Market cap | JP¥55.64b |
| Earnings (TTM) | JP¥5.92b |
| Revenue (TTM) | JP¥590.35b |
9.4x
P/E Ratio0.1x
P/S RatioIs 3151 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3151 income statement (TTM) | |
|---|---|
| Revenue | JP¥590.35b |
| Cost of Revenue | JP¥541.82b |
| Gross Profit | JP¥48.53b |
| Other Expenses | JP¥42.61b |
| Earnings | JP¥5.92b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 12, 2025
| Earnings per share (EPS) | 121.64 |
| Gross Margin | 8.22% |
| Net Profit Margin | 1.00% |
| Debt/Equity Ratio | 6.6% |
How did 3151 perform over the long term?
See historical performance and comparisonDividends
3.8%
Current Dividend Yield37%
Payout RatioDoes 3151 pay a reliable dividends?
See 3151 dividend history and benchmarks| Vital KSK Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 05 2025 |
| Days until Ex dividend | 96 days |
| Days until Dividend pay date | 165 days |
Does 3151 pay a reliable dividends?
See 3151 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 03:25 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Vital KSK Holdings, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jayaprabha Dhavale | Virtua Research Inc. |